Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bunker

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Child and Adolescent Psychopharmacology|April 1, 1997
Attenuation of antipsychotic-induced hyperprolactinemia with clozapineM T Bunker, P A Marken, M E Schneiderhan, et al.
Psychopharmacology Bulletin|January 1, 1996
Longitudinal analysis of abnormal involuntary movements in long-term clozapine-treated patientsM T Bunker, R W Sommi, S C Stoner, et al.
Neuropsychiatric Disease and Treatment|March 13, 2019
Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depressionArun Kumar, Mark T Bunker, Scott T Aaronson, et al.
International Journal of Bipolar Disorders|May 3, 2020
The effects of vagus nerve stimulation on the course and outcomes of patients with bipolar disorder in a treatment-resistant depressive episode: a 5-year prospective registryR Hamish McAllister-Williams, Soraia Sousa, Arun Kumar, et al.
Epilepsia|January 17, 2018
Long-term surveillance of SUDEP in drug-resistant epilepsy patients treated with VNS therapyPhilippe Ryvlin, Elson L So, Charles M Gordon, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 21, 2012
Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsySandra L Helmers, Mei Sheng Duh, Annie Guérin, et al.
Journal of Affective Disorders|February 18, 2026
Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trialA John Rush, Harold A Sackeim, Ying-Chieh Lisa Lee, et al.
Epilepsy & Behavior : E&B|August 30, 2011
Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsySandra L Helmers, Mei Sheng Duh, Annie Guérin, et al.
Journal of Psychiatric Research|April 12, 2019
The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF)Harold A Sackeim, Scott T Aaronson, Mark T Bunker, et al.
Journal of Affective Disorders|March 24, 2025
Characterizing the effects of vagus nerve stimulation on symptom improvement in markedly treatment-resistant major depressive disorder: A RECOVER trial reportHarold A Sackeim, Charles R Conway, Scott T Aaronson, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Child and Adolescent Psychopharmacology|April 1, 1997
Attenuation of antipsychotic-induced hyperprolactinemia with clozapineM T Bunker, P A Marken, M E Schneiderhan, et al.
Psychopharmacology Bulletin|January 1, 1996
Longitudinal analysis of abnormal involuntary movements in long-term clozapine-treated patientsM T Bunker, R W Sommi, S C Stoner, et al.
Neuropsychiatric Disease and Treatment|March 13, 2019
Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depressionArun Kumar, Mark T Bunker, Scott T Aaronson, et al.
International Journal of Bipolar Disorders|May 3, 2020
The effects of vagus nerve stimulation on the course and outcomes of patients with bipolar disorder in a treatment-resistant depressive episode: a 5-year prospective registryR Hamish McAllister-Williams, Soraia Sousa, Arun Kumar, et al.
Epilepsia|January 17, 2018
Long-term surveillance of SUDEP in drug-resistant epilepsy patients treated with VNS therapyPhilippe Ryvlin, Elson L So, Charles M Gordon, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 21, 2012
Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsySandra L Helmers, Mei Sheng Duh, Annie Guérin, et al.
Journal of Affective Disorders|February 18, 2026
Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trialA John Rush, Harold A Sackeim, Ying-Chieh Lisa Lee, et al.
Epilepsy & Behavior : E&B|August 30, 2011
Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsySandra L Helmers, Mei Sheng Duh, Annie Guérin, et al.
Journal of Psychiatric Research|April 12, 2019
The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF)Harold A Sackeim, Scott T Aaronson, Mark T Bunker, et al.
Journal of Affective Disorders|March 24, 2025
Characterizing the effects of vagus nerve stimulation on symptom improvement in markedly treatment-resistant major depressive disorder: A RECOVER trial reportHarold A Sackeim, Charles R Conway, Scott T Aaronson, et al.
Pageof 4